DEXLANSOPRAZOLE
Generic: DEXLANSOPRAZOLE
Mylan Pharmaceuticals Inc.Manufacturer
ORALRoute
DEXLANSOPRAZOLE SESQUIHYDRATEActive Substance
2024-01-19Original Approval
DEXLANSOPRAZOLE is FDA application ANDA205205, sponsored by MYLAN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
378 reports
2
CHRONIC KIDNEY DISEASE
334 reports
3
NAUSEA
299 reports
4
OFF LABEL USE
265 reports
5
FATIGUE
261 reports
6
DEATH
260 reports
7
DYSPNOEA
255 reports
8
ACUTE KIDNEY INJURY
216 reports
9
PAIN
211 reports
10
VOMITING
211 reports